COMPANY

Cytodel

HQ: New York, NY source · cytodel.com ↗ · Mid-Atlantic

Keywords: chronic pain protein engineering protein therapeutics

Location: New York, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

NIH awards 4

Annual award amounts. Total $934K.

Feb 21, 2023 NIH award 5R43NS122661-02 FY2023: $138,307 awarded for that fiscal year; activity R43 (SBIR); PI BAND, PHILIP ARTHUR; recipient as written: CYTODEL, INC., NEW YORK, NY. Recombinant botulinum toxin with improved safet source ↗
Dec 23, 2022 NIH award 1R43NS130849-01 FY2023: $295,365 awarded for that fiscal year; activity R43 (SBIR); PI BAND, PHILIP ARTHUR; recipient as written: CYTODEL, INC., NEW YORK, NY. Development of B8C1ad as an Orphan Drug for Iat source ↗
Mar 1, 2022 NIH award 1R43NS122661-01A1 FY2022: $276,617 awarded for that fiscal year; activity R43 (SBIR); PI BAND, PHILIP ARTHUR; recipient as written: CYTODEL, INC., NEW YORK, NY. Recombinant botulinum toxin with improved saf source ↗
Aug 29, 2014 NIH award 1R41NS086115-01A1 FY2014: $223,940 awarded for that fiscal year; activity R41 (STTR); PI BAND, PHILIP ARTHUR; recipient as written: CYTODEL, INC., NEW YORK, NY. Recombinant Botulinum Neurotoxin for Treatmen source ↗